These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36339086)

  • 1. Characteristics of Gut Microbiota in Female Patients with Diabetic Microvascular Complications.
    Gao S; Zhao LH; Tian X; Kong MW; He JQ; Ge XC; Liu XY; Feng ZB; Gao Y
    J Diabetes Res; 2022; 2022():2980228. PubMed ID: 36339086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy.
    Zhang L; Wang Z; Zhang X; Zhao L; Chu J; Li H; Sun W; Yang C; Wang H; Dai W; Yan S; Chen X; Xu D
    Microbiol Spectr; 2022 Aug; 10(4):e0032422. PubMed ID: 35863004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus.
    Ren Y; Hao L; Liu J; Wang P; Ding Q; Chen C; Song Y
    mSystems; 2023 Apr; 8(2):e0114622. PubMed ID: 36853013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterotype
    Wang J; Li W; Wang C; Wang L; He T; Hu H; Song J; Cui C; Qiao J; Qing L; Li L; Zang N; Wang K; Wu C; Qi L; Ma A; Zheng H; Hou X; Liu F; Chen L
    J Diabetes Res; 2020; 2020():6047145. PubMed ID: 32064276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota profile in healthy Indonesians.
    Rahayu ES; Utami T; Mariyatun M; Hasan PN; Kamil RZ; Setyawan RH; Pamungkaningtyas FH; Harahap IA; Wiryohanjoyo DV; Pramesi PC; Cahyanto MN; Sujaya IN; Juffrie M
    World J Gastroenterol; 2019 Mar; 25(12):1478-1491. PubMed ID: 30948911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of machine learning tools: Potential and useful approach for the prediction of type 2 diabetes mellitus based on the gut microbiome profile.
    Ge X; Zhang A; Li L; Sun Q; He J; Wu Y; Tan R; Pan Y; Zhao J; Xu Y; Tang H; Gao Y
    Exp Ther Med; 2022 Apr; 23(4):305. PubMed ID: 35340868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of gut dominant microbiota with hyperuricemia.
    Ji Z; Xu M; Jin C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 52(2):207-213. PubMed ID: 37283105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
    Huang JX; Liao YF; Li YM
    Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.
    Wang L; Liang C; Song X; Jia X; Wang X; Zhang Y; Xie Q; Zheng N; Yuan H
    Front Endocrinol (Lausanne); 2023; 14():1256292. PubMed ID: 37867512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the Microbiota and their Roles in Patients with Type 2 Diabetes Mellitus.
    He QL; Wang HC; Ma YK; Yang RL; Dai ZF; Yang JN; Xu Y; Wei DD; Zhu LP; Lin XH
    Curr Microbiol; 2023 Mar; 80(4):132. PubMed ID: 36894807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
    Shao J; Liu Y; Wang H; Luo Y; Chen L
    Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis.
    Zheng Y; Ding Q; Wei Y; Gou X; Tian J; Li M; Tong X
    Phytomedicine; 2021 Jul; 88():153455. PubMed ID: 33478831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclocarya paliurus leaves extracts alleviate metabolic phenotypes in Chinese T2DM patients by modulating gut microbiota and metabolites: a clinical randomized controlled trial.
    Peng X; Chen S; Zhong L; Li Y; Wu C; Zhong L; Chen W; Yang J; Zeng J; Tang S
    Front Endocrinol (Lausanne); 2023; 14():1176256. PubMed ID: 37293505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between serum 1, 5-anhydroglucitol level and insulin resistance, microvascular complications in type 2 diabetes mellitus].
    Tan AC; Zhang Q; Cheng J; Yan XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Jun; 58(6):875-882. PubMed ID: 38955736
    [No Abstract]   [Full Text] [Related]  

  • 15. Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.
    Tsai HJ; Tsai WC; Hung WC; Hung WW; Chang CC; Dai CY; Tsai YC
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects.
    Carrizales-Sánchez AK; Tamez-Rivera O; Rodríguez-Gutiérrez NA; Elizondo-Montemayor L; Gradilla-Hernández MS; García-Rivas G; Pacheco A; Senés-Guerrero C
    BMC Pediatr; 2023 May; 23(1):210. PubMed ID: 37138212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of microvascular complications in patients with new diagnosis type 2 diabetes.
    Yaprak B; Keskin L
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1601-1608. PubMed ID: 36876708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alteration of gut microbiota in newly diagnosed type 2 diabetic patients.
    Chen PC; Chien YW; Yang SC
    Nutrition; 2019; 63-64():51-56. PubMed ID: 30933725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
    Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
    Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease.
    Jin LT; Xu MZ
    Front Cell Infect Microbiol; 2023; 13():1113643. PubMed ID: 36756620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.